Minette (Chlormadinone Acetate, Ethinylestradiol)

Chlormadinone acetate, the active ingredient in Minette, is a combined oral contraceptive (progestogen and estrogen) presented as a tablet for oral use. It is prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Minette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality manufacturing, regulatory compliance across EU and global markets, and providing reliable sourcing, batch testing, and documentation to meet the needs of healthcare providers.

Minette is a combined oral contraceptive that works on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy. - Prevention of pregnancy: provides reliable contraception for women of child‑bearing potential by suppressing ovulation and modifying cervical mucus.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional mild to moderate pain. - Weight gain: slight increase in body weight. - Mood changes: irritability or mild mood swings. - Spotting between periods: irregular light bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Hypertension: new or worsening high blood pressure. - Liver dysfunction: jaundice or hepatic adenoma. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Visual disturbances: sudden vision changes or loss.

Before prescribing Minette, clinicians should assess individual risk factors and counsel patients on safe use. - VTE risk assessment: evaluate personal or family history of clotting disorders. - Smoking cessation: advise women over 35 who smoke to quit. - Liver disease monitoring: avoid use in active liver disease. - Blood pressure check: monitor for hypertension during therapy. - Drug interaction review: verify concomitant medications that may affect efficacy. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Minette may interact with several medicines that alter hormone metabolism. Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): may reduce contraceptive effectiveness. - Certain antiretrovirals (e.g., efavirenz): can lower hormone levels. - St. John’s wort: potent CYP3A4 inducer, decreasing efficacy. Moderate Interactions (Monitor Closely): - Moderate CYP3A4 inducers (e.g., griseofulvin, phenobarbital): may modestly reduce effectiveness. - Antibiotics such as tetracycline or metronidazole: occasional reduction in hormone levels. - Antifungal agents (e.g., fluconazole): may increase hormone concentrations, watch for side effects.